Key facts
- Notable investors include Enterprise Ireland, Furthr.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Biovit Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Biovit Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biovit Technologies
Developer of nutrient absorption technology intended to maximize the value of vitamins, nutrients, and fortified foods. The company specializes in driving the absorption of nutrients into the body by enhancing the functional value of foods, beverages, and supplements with the absorption of key nutrients and ultimately improving public health outcomes, enabling food and beverage businesses to incorporate these raw nutrients into eatables, drinks, and dietary supplements.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2023
- Employees
- 6
- Website
- biovit.ie/
- Ownership
- Privately Held (backing)
Biovit Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biovit Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biovit Technologies in its N-PORT filings yet. We sweep new filings monthly.